2024 PharmD Business Plan Competition - The Grand Finale

On Tuesday, March 26 from 6pm to 8pm EST, you will have the opportunity to see the top Six Teams present at the Grand Finale of the Leslie Dan Faculty of Pharmacy Business Plan Competition. 

The Annual Business Plan Competition provides an opportunity for students at the Leslie Dan Faculty of Pharmacy to bring together their clinical and business skills to create novel solutions that can improve individual patient care and have a positive impact on the wider healthcare system.

The top three teams will be awarded a total of $10,000.

1st prize - $5000
2nd prize - $3000
3rd prize - $2000

Registration

Judging Panel

Dr. Zubin Austin

Zubin Austin BScPhm MBA MISc PhD FCAHS is Professor and Koffler Research Chair at the Leslie Dan Faculty of Pharmacy and the Institute for Health Policy, Management, and Evaluation at the Temerty Faculty of Medicine – University of Toronto.  His research focuses on the professional and personal development of the health workforce.  He has published over 200 peer reviewed manuscripts and authored 4 textbooks. In 2017, in recognition of the societal impact of his research, he was installed as a Fellow of the Canadian Academy of Health Sciences, one of the highest honours for health researchers in Canada.  He is also the only University of Toronto professor ever to have received both the President’s Teaching Award for sustained excellence as an educator and the President’s Research Impact Award for the global significance of his work.  He has been named undergraduate Professor of the Year by students on 20 separate occasions.

Emily Musing

Emily Musing is an Associate Professor with the Leslie Dan Faculty of Pharmacy and with the Institute of Health Policy Management and Evaluation, and an affiliate member of the Centre for Patient Safety, University of Toronto. She is the the former Vice President, Quality and Safety and Chief Patient Safety Officer at the University Health Network in Toronto, Canada, where she led both inpatient and outpatient pharmacy services across UHN’s many sites. She was also responsible for providing leadership related to Infection Prevention and Control, Antimicrobial Stewardship Program and the Patient Safety Team.

Emily received her Bachelor of Science in Pharmacy from the Faculty of Pharmacy, University of Toronto and her Masters of Health Science in Health Administration from the Institute of Health Policy Management and Evaluation, University of Toronto.

Jamie Stiff

Mr. Stiff joined Genesys Capital in 2002 and became Partner at the firm in 2007 and Managing Director in 2016. During his tenure with Genesys, he has been responsible for investments in several early-stage portfolio companies that cross a multitude of clinical disciplines and technology areas. Current board affiliations include EBT Medical, Inc., Giiant Pharma Inc., Inversago Pharma Inc. and Veralox Therapeutics, Inc. Past board affiliations include Allostera Pharma, Fairhaven Pharmaceuticals (acquired by Liminal BioSciences Inc. NASDAQ:LMNL), gIcare Pharma, Interface Biologics, Matregen, Naurex (acquired by Allergan NYSE:AGN), NeurAxon, StemPath, Therapeutic Monitoring Systems and Zelos Therapeutics. Mr. Stiff also volunteers as a board member for BioteCanada, and as an advisor to the Ontario Genomics Institute (OGI), the Centre for Commercialization of Regenerative Medicine (CCRM) and Medicine by Design and as an associate with the Creative Destruction Lab (CDL).

Prior to joining Genesys, Mr. Stiff worked at the Samuel Lunenfeld Research Institute at Mount Sinai Hospital in the genetic diagnostics field. This experience, combined with an academic background in biology, has provided significant technical knowledge of many areas of life sciences. Mr. Stiff completed a Bachelor of Science (Honours) from Queen’s University and an MBA from the Rotman School of Management.